Mesoblast Ltd Files 6-K with SEC
Ticker: MEOBF · Form: 6-K · Filed: Oct 3, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, press-release
TL;DR
MESOBLAST LTD filed a 6-K on Oct 3, 2025, attaching a press release.
AI Summary
On October 3, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a press release previously announced on the Australian Securities Exchange. This filing is for the month of October 2025 and indicates Mesoblast Limited is a foreign private issuer filing under Form 20-F.
Why It Matters
This filing provides an update on Mesoblast Limited's reporting to the SEC, confirming their status as a foreign private issuer and incorporating a recent press release.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates a previously issued press release and confirms the company's reporting status.
Key Numbers
- 001-37626 — SEC File Number (Identifies Mesoblast Limited's filings with the SEC.)
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- October 3, 2025 (date) — Filing Date
- 001-37626 (company) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K filing is to report information that Mesoblast Limited has made or is required to make public in Australia, filed for the month of October 2025.
What exhibit is attached to this Form 6-K?
Exhibit 99.1, a new release announcement filed with the Australian Securities Exchange, is attached to this Form 6-K.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited's jurisdiction of incorporation or organization is Australia.
Does Mesoblast Limited file an annual report under Form 20-F or Form 40-F?
Mesoblast Limited indicates it files annual reports under cover of Form 20-F.
Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2025-10-02 21:35:38
Filing Documents
- form6-kxpressreleasecoverf.htm (6-K) — 15KB
- exhibit991ryoncilcmsj-co.htm (EX-99.1) — 9KB
- exhibit991ryoncilcmsj-co001.jpg (GRAPHIC) — 264KB
- exhibit991ryoncilcmsj-co002.jpg (GRAPHIC) — 256KB
- 0001345099-25-000081.txt ( ) — 740KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated October 3, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated October 3, 2025.